论文部分内容阅读
无关供者骨髓移植(ＢＭＴ)后复发输注供者白细胞(ＤＬＩ)的效果和毒性仍不明确,作者从国家骨髓供者计划资料中选出５８例用无关ＤＬＩ(ＵＤＬＩ)治疗白血病复发的病例。方法 回顾性分析ＵＤＬＩ的反应率、毒性和存活率及治疗成功的相关因素。ＵＤＬＩ用于慢性髓系白血病(ＣＭＬ)２５例,急性髓系白血病
The efficacy and toxicity of transfusional donor leukocytes (DLI) after unrelated donor BMT remains unclear. The authors selected 58 patients with leukemia relapsed with unrelated DLI (UDLI) from the National Marrow Donor Program data . Methods Retrospective analysis of the response rate, toxicity and survival rate of UDLI and related factors of successful treatment. UDLI for chronic myeloid leukemia (CML) 25 cases of acute myeloid leukemia